Malignant melanoma with neuroendocrine differentiation: Clinical, histological, immunohistochemical and ultrastructural features of three cases

Histopathology

Volumn 47, Issue 4, 2005, Pages 402-409

  Eyden, Brian ^a   Pandit, D ^a   Banerjee, S S ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Chromogranin; Electron microscopy; HMB 45; Malignant melanoma with neuroendocrine differentiation

Indexed keywords

CHROMOGRANIN; HMB 45 ANTIGEN; MELAN A; MONOPHENOL MONOOXYGENASE; NEUROFILAMENT PROTEIN; PROTEIN S 100; SYNAPTOPHYSIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; CASE REPORT; CELL DIFFERENTIATION; CELL ULTRASTRUCTURE; CLINICAL FEATURE; ELECTRON MICROSCOPY; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MELANOMA; MELANOSOME; NEUROSECRETORY CELL; NOSE MUCOSA; PRIORITY JOURNAL; SKIN TUMOR; TUMOR CELL;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MELANOMA; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NOSE NEOPLASMS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 26444584476     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02240.x     Document Type: Article

References (44)

1. Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000; 36; 387-402.
2. Rode J, Dhillon AP. Neurone specific enolase and S100 protein as possible prognostic indicators in melanoma. Histopathology 1984; 8; 1041-1052.
3. Gatter KC, Ralfkaier E, Skinner J et al. An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours. J. Clin. Pathol. 1985; 38; 1353-1357.
4. Palmer AA, Hall BE, Lew M. A comparison of some methods for identifying amelanotic and oligomelanotic melanoma metastases in paraffin sections. Pathology 1985; 17; 335-339.
5. Hirano T. Immunohistochemical study of malignant melanoma. Acta Pathol. Jpn 1986; 36; 733-743.
6. Jundt G, Schulz A, Paul E et al. S-100 protein in amelanotic melanoma. A convenient immunocytochemical approach compared to electron microscopy. Pathol. Res. Pract. 1986; 181; 37-44.
7. Angeli S, Koelma IA, Fleuren GJ et al. Malignant melanoma in fine needle aspirates and effusions. An immunohistochemical study using monoclonal antibodies. Acta Cytol. 1988; 32; 707-712.
8. Ordónez NG, Ji X, Hickey RC. Comparison of HMB-45 monoclonal antibody and S100 protein in the immunohistochemical diagnosis of melanoma. Am. J. Clin. Pathol. 1988; 90; 385-390.
9. Steuhl K-P, Rohrbach JM, Knorr M et al. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors. Ophthalmology 1993; 100; 208-215.
10. Orosz Z. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours. Histopathology 1999; 34; 517-525.
11. Yaziji H, Gown AM. Immunohistochemical markers of melanocytic tumors. Int. J. Surg. Pathol. 2003; 11; 11-15.
12. Chang KL, Folpe AL. Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. Adv. Anat. Pathol. 2001; 8; 273-275.
13. O'Reilly FM, Brat DJ, McAlpine BE et al. Microphthalmia transcription factor immunohistochemistry: useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms. J. Am. Acad. Dermatol. 2001; 45; 414-419.
14. Granter SR, Weilbaecher KN, Quigley C et al. Role of microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma. Appl. Immunohistochem. Mol. Morph. 2002; 10; 47-51.
15. Miettinen M, Franssila K. Immunohistochemical spectrum of malignant melanoma. The common presence of keratins. Lab. Invest. 1989; 61; 623-628.
16. Allen BC, Herrera GA. Phenotypic cytoskeletal heterogeneity in melanoma, a challenge to the surgical pathologist evaluating a poorly differentiated neoplasm: an illustrative case. Ultrastruct. Pathol. 1991; 15; 87-97.
17. Franquemont DW, Mills SE. Sinonasal malignant melanoma. A clinicopathologic and immunohistochemical study of 14 cases. Am. J. Clin. Pathol. 1991; 96; 689-697.
18. Feely C, Theaker J. Epithelial markers in primary sinonasal mucosal melanoma. Histopathology 2004; 45; 96-98.
19. Shah IA, Gani OS, Wheler L. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi. Pathol. Res. Pract. 1997; 193; 497-502.
20. Coli A, Giacomini PG, Bigotti G et al. Aberrant neurofilament protein and synaptophysin expression in malignant melanoma of the nasal cavity. Histopathology 2004; 44; 193-195.
21. Michels S, Swanson PE, Robb JA et al. Leu-7 in small-cell neoplasms. An immunohistochemical study with ultrastructural correlations. Cancer 1987; 60; 2958-2964.
22. Swanson PE, Wick MR. Clear cell sarcoma. An immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue. Arch. Pathol. Lab. Med. 1989; 113; 55-60.
23. Mooy CM, Luyten GP, de Jong PT et al. Neural cell adhesion molecule distribution in primary and metastatic uveal melanoma. Hum. Pathol. 1995; 26; 1185-1190.
24. Prieto VG, McNutt NS, Lugo J et al. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions. J. Cutan. Pathol. 1997; 24; 145-150.
25. Banerjee SS, Menasce LP, Eyden BP et al. Malignant melanoma showing ganglioneuroblastic differentiation: report of a unique case. Am. J. Surg. Pathol. 1999; 23; 582-588.
26. Anastassiou G, Schilling H, Stang A et al. Expression of the cell adhesion molecules ICAM-1, VCAM-1 and NCAM in uveal melanoma: a clinicopathological study. Oncology 2000; 58; 83-88.
27. Lum SS, Fletcher WS, O'Dorisio MS et al. Distribution and functional significance of somatostatin receptors in malignant melanoma. World J. Surg. 2001; 25; 407-412.
28. Grayson W, Maré LR. Ganglioneuroblastic differentiation in a primary cutaneous malignant melanoma. Am. J. Dermatopathol. 2003; 25; 40-44.
29. McDonald SL, Edington HD, Kirkwood JM et al. Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes. Cancer Biol. Ther. 2004; 3; 110-120.
30. Miettinen M, Cupo W. Neural cell adhesion molecule distribution in soft tissue tumors. Hum. Pathol. 1993; 24; 62-66.
31. Zeromski J, Nyczak E, Dyszkiewicz W. Significance of cell adhesion molecules, CD56/NCAM in particular, in human growth and spreading. Folia Histochem. Cytobiol. 2001; 39 (Suppl. 2); 36-37.
32. Eyden B. Organelles in tumor diagnosis. An ultrastructural atlas. Tokyo: Igaku-Shoin 1996; 28-31.
33. Mackay B, Ayala AG. Intracisternal tubules in human melanoma. Ultrastruct. Pathol. 1980; 1; 1-6.
34. Hunter JAA, Zaynoun S, Paterson WD et al. Cellular fine structure in the invasive nodules of different histogenetic types of malignant melanoma. Br. J. Dermatol. 1978; 98; 255-272.
35. Hunter JAA, Mottaz JH, Zelickson AS. Melanogenesis: ultrastructural histochemical observations on ultraviolet irradiated human melanocytes. J. Invest. Dermatol. 1970; 54; 213-221.
36. Ho FCS, Ho JCI. Pigmented carcinoid tumour of the thymus. Histopathology 1977; 1; 363-369.
37. Cebelin MS. Melanocytic bronchial carcinoid tumor. Cancer 1980; 46; 1843-1848.
38. Gould VE, Memoli VA, Dardi LE et al. Neuroendocrine carcinomas with multiple immunoreactive peptides and melanin production. Ultrastruct. Pathol. 1981; 2; 199-217.
39. Marcus JN, Dise CA, LiVolsi VA. Melanin production in a medullary thyroid carcinoma. Cancer 1982; 49; 2518-2526.
40. Lagrange W, Dahm H-H, Karstens J et al. Melanocytic neuroendocrine carcinoma of the thymus. Cancer 1987; 59; 484-488.
41. Eng H-I, Chen W-J. Melanin-producing medullary carcinoma of the thyroid gland. Arch. Pathol. Lab. Med. 1989; 113; 377-380.
42. Gal AA, Koss MN, Hochholzer HH et al. Pigmented pulmonary carcinoid tumor. An immunohistochemical and ultrastructural study. Arch. Pathol. Lab. Med. 1993; 117; 832-836.
43. Klemm KM, Moran CA, Suster S. Pigmented thyrnic carcinoids: a clinicopathological and immunohistochemical study of two cases. Mod. Pathol. 1999; 12; 946-948.
44. Kuo T-T. Pigmented spindle cell carcinoid tumour of the thymus with ectopic adrenocorticotropic hormone secretion: report of a rare variant and differential diagnosis of mediastinal spindle cell neoplasms. Histopathology 2002; 40; 159-165.